|
Repatha Lipodystrophy
|
|
|
Download the PDF here
Download the PDF here
Download the PDF here
I have received a HIV+ patient communication directly from the patient who reports a 90-95% reversal of facial lipoatrophy & increased rear end fat, he had never had belly fat so nothing to report on that, this is after treatment with Repatha, the PCKS9 inhibitor from Amgen. I have communicated with the research medical team at amgen & the lead investigator of the just enrolling HIV Repatha study but its too late to look at this in their study.
Jules Levin
www.natap.org
Here is the Descartes Repatha study which I think provides some insights into the metabolic affects of Repatha & here also is FDA Review. And the Spplementary Appendix which reports breakdown in more detail of metabolic changes.
|
|
|
|
|
|
|